Project Grant R01AI173045
- This federal Project Grant award for $640,129 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to decipher the regulatory networks of Borrelia burgdorferi (the bacteria that causes Lyme disease) as it transitions between tick vectors and mammalian hosts. The research aims to understand how the RpoS regulatory pathway controls gene expression to enable B. burgdorferi's dual-host lifestyle. Key objectives...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $165,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Tufts University School of Medicine to develop an improved transposon mutagenesis system for comprehensive genetic analysis of Borrelia burgdorferi, the bacterium that causes Lyme disease. The project, running from July 1, 2025 to June 30, 2027, aims to create a high-efficiency transposon insertional mutagenesis system...
- This Project Grant award of $457,875.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) supports research to elucidate how the alternative sigma factor RpoS regulates gene expression in Borrelia burgdorferi and contributes to the persistence of the Lyme disease spirochete in the mammalian host. The key objectives are to 1) interrogate individual RpoS-regulated genes throughout the course...
- The U.S. Defense Health Agency awarded a $542,500 Project Grant to Worcester Polytechnic Institute (WPI) under the Military Medical Research and Development program (CFDA 12.420) to support a novel in vitro platform to study Borrelia burgdorferi pathogenesis and genetic susceptibility to Lyme disease. The grant, titled "MSHOST: A Novel Human In Vitro Genome-Wide Association Platform to Study B Burgdorferi Pathogenesis and Genetic Susceptibility to Lyme Disease," will be performed...
- The National Institute of Allergy and Infectious Diseases (NIAID), through its Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $429,000 Project Grant to The Medical College of Wisconsin, Inc. to study the effect of Borrelia burgdorferi-SIRPα interaction on the immune response. The research aims to understand how the Lyme disease pathogen B. burgdorferi can evade phagocytic clearance by macrophages, a key component of the innate immune system, through molecular mimicry...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to characterize how the host protein epidermal growth factor (EGF) interacts with the Lyme disease bacterium Borrelia burgdorferi to coordinate its stage-specific gene expression. The $162,000 award, with a project period from May 2025 to April 2027, will enable the Johns Hopkins University to conduct...
- This Project Grant award, totaling $461,375, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research by Yale University to systematically identify interactions between Lyme disease bacteria, Borrelia burgdorferi, and the extracellular, secreted and transmembrane proteins of its tick vector, Ixodes scapularis. The research aims to develop a high-throughput screening...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is providing $3,315,179 to Tufts University School of Medicine in Boston, Massachusetts to conduct research on the microbial determinants of excessive inflammation and severe Lyme disease. The research aims to systematically delineate the immunogenic lipoproteins of the Borrelia burgdorferi bacterium and ascertain their...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $191,250 to Washington State University (WSU) to conduct research on the immune evasion mechanism of the Lyme disease spirochete, Borrelia burgdorferi. The award supports mechanistic studies on the role of genetic factors in the antigenic variation of the VlsE surface protein, a key mechanism for persistent...
- This $199,984 Project Grant awarded by the National Science Foundation (NSF) Engineering program (CFDA 47.041) aims to increase the fundamental understanding of the immune response to various Lyme disease antigens using bacterial outer membrane vesicles (OMVs) as a novel carrier system. The research objectives are to: 1) explore fusion proteins as a proof of concept to present full Borrelia burgdorferi (BB) antigens on OMVs, 2) determine the potential to express multiple BB antigen epitopes on...
PHAGE-MEDIATED HORIZONTAL GENE TRANSFER IN BORRELIA BURGDORFERI - PROJECT SUMMARY/ABSTRACT LYME DISEASE IS CAUSED BY INFECTION WITH THE SPIROCHETE BORRELIA (BORRELIELLA) BURGDORFERI. THESE SPIROCHETES ARE THEMSELVES INFECTED BY THE PHAGE FBB-1. PHAGES ARE VIRUSES THAT INFECT BACTERIA AND ARE THE MOST UBIQUITOUS BIOLOGICAL ENTITIES ON THE PLANET. FBB-1 IS A TEMPERATE PHAGE, WHICH HAS TWO TYPES OF REPLICATION: THE LYTIC CYCLE INVOLVES ASSEMBLY OF PHAGE PARTICLES FOLLOWED BY RELEASE OUTSIDE OF THE BACTERIUM AND LYSOGENIC CYCLE INVOLVES INCORPORATION OF THE PHAGE INTO THE BACTERIAL GENOME. THE FBB-1 PROPHAGE ARE THE CP32S, A LARGE GROUP OF NEARLY IDENTICAL 32-KB CIRCULAR PLASMIDS UNIVERSALLY FOUND IN EVERY SPECIES OF BORRELIA. THE CENTRAL HYPOTHESIS OF THIS APPLICATION IS THAT FBB-1 PHAGE DRIVE HORIZONTAL GENE TRANSFER OF ANTIGENS BETWEEN B. BURGDORFERI STRAINS AND THAT THIS PROCESS MAINTAINS THE SPIROCHETE IN ITS RESERVOIR HOST, ALLOWING FOR REINFECTION OF INDIVIDUALS. THERE HAVE BEEN VERY FEW STUDIES ON THE BIOLOGY OF FBB-1 AND ITS ROLE IN TRANSDUCTION, THE MOVEMENT OF GENETIC MATERIAL BETWEEN INDIVIDUAL B. BURGDORFERI SPIROCHETES BY THE FBB-1 PHAGE. WE ENDEAVOR TO UNCOVER THE MECHANISM REGULATING FBB-1 REPLICATION AND THE EFFECT OF TRANSDUCTION ON THE ABILITY OF B. BURGDORFERI TO CYCLE BETWEEN ITS TICK VECTOR AND VERTEBRATE HOST. THE FOLLOWING SPECIFIC AIMS ARE PROPOSED TO ACCOMPLISH THESE RESEARCH GOALS: 1) MEASURE HORIZONTAL GENE TRANSFER BETWEEN HETEROLOGOUS BB STRAINS IN THE TICK VECTOR; 2) DEFINE THE ROLE OF FBB-1 IN MAINTAINING SPIROCHETE INFECTIVITY IN PREVIOUSLY INFECTED MICE; AND 3) DISSECT THE MECHANISM OF THE FBB-1 LYSIS/LYSOGENY DECISION. GENETIC, GENOMIC, BIOCHEMICAL, AND TRANSCRIPTOMIC APPROACHES, AS WELL AS THE TICK-MOUSE MODEL OF LYME DISEASE, WILL BE UTILIZED TO EXPERIMENTALLY PURSUE THESE AIMS. IN THIS INNOVATIVE APPLICATION, THE TEAM OF PIS HAVE GENERATED COMPELLING PRELIMINARY DATA AND ARE IN THE UNIQUE POSITION OF HAVING THE EXPERIENCE, EXPERTISE, AND EXPERIMENTAL MODELS TO ENHANCE THE MECHANISTIC UNDERSTANDING OF FBB-1 BIOLOGY, INCLUDING THE REGULATION OF REPLICATION DECISIONS AND THE CONSEQUENCES OF TRANSDUCTION ON THE ABILITY OF B. BURGDORFERI TO INFECT PREVIOUSLY INFECTED HOSTS. THE LONG-TERM OBJECTIVE OF THIS PROPOSAL IS TO UNDERSTAND THE ROLE OF FBB-1 PHAGE ON B. BURGDORFERI MICROBIOLOGY AND LYME DISEASE PATHOGENESIS, WHICH WILL LEAD TO IMPROVED DIAGNOSTIC, PREVENTION, AND TREATMENT STRATEGIES BECAUSE GENETIC DIVERSITY IS REQUIRED FOR THE MAINTENANCE OF B. BURGDORFERI IN ITS TICK-VERTEBRATE CYCLE AS WELL AS FOR THE REINFECTION OF PREVIOUS LYME DISEASE PATIENTS; THIS IS RELEVANT TO THE MISSION OF THE AGENCY TO "SEEK FUNDAMENTAL KNOWLEDGE" FOR THE SAKE OF ALLEVIATING HUMAN DISEASE.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $574.3k | 7/7/25 | ||
| Not listed | $144.6k | 5/6/25 | ||
| Not listed | $144.6k | 5/6/25 | ||
| Not listed | ($145k) | 5/6/25 | ||
| Not listed | ($145k) | 5/6/25 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
G15725WB341S | University Of Montana | Project Grant R01AI173045 | $211.4k | 11/1/24 |